Moneycontrol PRO
HomeNewsBusinessCompaniesBiocon Inc recalls 5,505 bottles of Simvastatin tablets in US

Biocon Inc recalls 5,505 bottles of Simvastatin tablets in US

The 5,505 bottles of Simvastatin tablets in the strength of 5 mg are being recalled in a firm initiated ongoing recall due to the product being a 'subpotent drug', the United States Food and Drug Administration (USFDA) said in its latest Enforcement Report.

April 20, 2016 / 20:26 IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Biocon Inc, part of biotechnology major Biocon, is recalling in the US 5,505 bottles of cholesterol lowering Simvastatin tablets for being sub-potent, according to the USFDA.

The 5,505 bottles of Simvastatin tablets in the strength of 5 mg are being recalled in a firm initiated ongoing recall due to the product being a 'subpotent drug', the United States Food and Drug Administration (USFDA) said in its latest Enforcement Report.

The tablets are manufactured by Blu Caribe Dorado for Blu Pharmaceuticals Franklin, it added.

When contacted a Biocon spokesperson told PTI: "The Class III recall for 5 mg tablets of simvastatin pertains to a specific lot manufactured by Blu Caribe (Puerto Rico, USA) for Blu Pharmaceuticals (Kentucky, USA) long before Biocon acquired the simvastatin ANDA from Blu." The FDA notified Biocon "as we are the current holders of the ANDA", she added.

Although as per information on the USFDA site, the recall is ongoing, the Biocon spokespseron said: "Blu has successfully initiated and completed the recall. Biocon has not manufactured and supplied any simvastatin tablets to date." The recall is a class III recall, the US health regulator said.

As per the USFDA a class III is initiated in a situation "in which use of, or exposure to, a violative product is not likely to cause adverse health consequences".

first published: Apr 20, 2016 08:02 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347